These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 7032940)
21. [Use of adriablastine in the combined chemotherapy of breast cancer patients with bone metastases]. Korman DB; Borisov AI; Maslova IA; Dobroskok LB Vopr Onkol; 1980; 26(8):20-4. PubMed ID: 7415044 [TBL] [Abstract][Full Text] [Related]
22. Elliptinium: phase II study in advanced measurable breast cancer. Treat J; Greenspan A; Rahman A; McCabe MS; Byrne PJ Invest New Drugs; 1989 Jul; 7(2-3):231-4. PubMed ID: 2793378 [TBL] [Abstract][Full Text] [Related]
23. Oral pamidronate in the prevention and treatment of skeletal metastases in patients with breast cancer. van Holten-Verzantvoort AT; Papapoulos SE Medicina (B Aires); 1997; 57 Suppl 1():109-13. PubMed ID: 9567363 [TBL] [Abstract][Full Text] [Related]
24. A phase II study of Mitomycin C in refractory adcvanced breast cancer. A multi-centre pilot study. van Oosterom AT; Powles TJ; Hamersma E; Smith IE; Engelsman E Eur J Cancer (1965); 1980; Suppl 1():275-6. PubMed ID: 6797825 [No Abstract] [Full Text] [Related]
25. [A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases]. Sueyoshi K; Ogura Y; Komori T; Takahashi M; Tian TX; Tatsumi T; Matsuki M; Saika Y; Uesugi Y; Utsunomiya K; Inomata Y; Narabayashi I Gan To Kagaku Ryoho; 2002 Oct; 29(10):1795-9. PubMed ID: 12402432 [TBL] [Abstract][Full Text] [Related]
26. Off-trial evaluation of bisphosphonates in patients with metastatic breast cancer. Liauw W; Segelov E; Lih A; Dunleavy R; Links M; Ward R BMC Cancer; 2005 Jul; 5():89. PubMed ID: 16048654 [TBL] [Abstract][Full Text] [Related]
27. The role of bisphosphonates in early breast cancer. Paterson AH Oncologist; 2006; 11 Suppl 1():13-9. PubMed ID: 16971735 [TBL] [Abstract][Full Text] [Related]
28. [Clinical trial of fadrozole hydrochloride for postmenopausal patients with recurrent breast cancer]. Kanzaki M; Nakaya Y; Kojima K; Toda H; Tobayama S; Machida H; Ohba M Gan To Kagaku Ryoho; 1999 Jun; 26(7):959-65. PubMed ID: 10396324 [TBL] [Abstract][Full Text] [Related]
29. [Therapy of bone metastases in case of mastocarcinoma (author's transl)]. Gottwald G; Szakolczai I Strahlentherapie; 1981 Dec; 157(12):801-7. PubMed ID: 7330908 [No Abstract] [Full Text] [Related]
30. [Biphosphonates in breast cancer--based on a Cochrane meta-analysis]. Junker N; Nielsen DL; Kamby C Ugeskr Laeger; 2007 Sep; 169(37):3108-11. PubMed ID: 17877961 [No Abstract] [Full Text] [Related]
31. [Neoadjuvant intra-arterial infusion chemotherapy for the treatment of locally advanced breast cancer with remote metastases]. Nakagawa H; Takatsuka Y; Shin E; Mishima H; Tono T; Tamaki Y; Yagyu T; Kobayashi K; Kikkawa N Gan To Kagaku Ryoho; 1994 Sep; 21(13):2274-7. PubMed ID: 7944458 [TBL] [Abstract][Full Text] [Related]
32. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer. Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784 [TBL] [Abstract][Full Text] [Related]
33. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer. Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715 [TBL] [Abstract][Full Text] [Related]
34. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases]. Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740 [TBL] [Abstract][Full Text] [Related]
35. Clinical trials in metastatic breast cancer to bone: past--present--future. Body JJ Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of zoledronic acid in patients with breast cancer metastatic to bone: a multicenter clinical trial. Cartenì G; Bordonaro R; Giotta F; Lorusso V; Scalone S; Vinaccia V; Rondena R; Amadori D Oncologist; 2006; 11(7):841-8. PubMed ID: 16880243 [TBL] [Abstract][Full Text] [Related]
37. [Chemotherapy in metastasing breast cancer--is it beneficial?]. Høgsberg IM; Nielsen MM; Cold S; Rose C Ugeskr Laeger; 1994 Oct; 156(44):6549-50. PubMed ID: 7825256 [TBL] [Abstract][Full Text] [Related]
38. [Clinical experiences with Masterid]. Heine R Med Welt; 1971 Apr; 17():718-20. PubMed ID: 4930464 [No Abstract] [Full Text] [Related]
39. Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study. Hultborn R; Gundersen S; Ryden S; Holmberg E; Carstensen J; Wallgren UB; Killany S; Andreassen L; Carlsson G; Fahl N; Hatschek T; Sommer HH; Hessman Y; Hornmark-Stenstam B; Johnsborg S; Klepp R; Laino R; Niklasson LG; Rudenstam CM; Sundbeck A; Söderberg M; Tejler G Anticancer Res; 1999; 19(4C):3383-92. PubMed ID: 10629624 [TBL] [Abstract][Full Text] [Related]
40. Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer. Lipton A; Harvey HA; Santen RJ; Boucher A; White D; Bernath A; Dixon R; Richards G; Shafik A Cancer Res; 1982 Aug; 42(8 Suppl):3434s-3436s. PubMed ID: 7044526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]